VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > overall economics

<< Previous

Bullboard Posts

Next >>

Post by bluemoons20on Mar 13, 2021 1:17pm

326 Views

Post# 32793056

overall economics

Hi,
Does someone know the overall economics of this deal?
See some projections that it may be bought out @ $10 but how do you get there??

How much does a unit sell for? Thought I read somewhere about $50,000 The number of hospitals in Canada is a little over 1000 and in the US about 6000. If the numbers are right and you sell 2000 units , thats about 100 million. With 125 million shares out, that is less than $1 per share presuming 100% margin. Likely training goes with it so there will be some cost.

Can anyone shed some light on this for me? I can see an overall value in the product but does it have real economics?

Thanks for any input

<< Previous

Bullboard Posts

Next >>

Aston Bay unearths thick new copper zones in Nunavut